Evidence map›Paper›PMID 39152038›Full record

ArticleGenome research2024

Allele-specific transcription factor binding across human brain regions offers mechanistic insight into eQTLs.

Ashlyn G Anderson, Belle A Moyers, Jacob M Loupe, Ivan Rodriguez-Nunez, Stephanie A Felker, James M J Lawlor, William E Bunney, Blynn G Bunney, Preston M Cartagena, Adolfo Sequeira and 5 more

Abstract read
In one paragraph

Article in Genome research, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Promoter mutagenesis and a massively parallel reporter screen of thebioRxiv : the preprint server for biology · 2026
    Article
  3. Article
  4. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

15 authors.

Ashlyn G AndersonHudsonAlpha Institute for Biotechnology, Huntsville, Alabama 35806, USA.ORCID 0000-0003-0090-706X
Belle A MoyersHudsonAlpha Institute for Biotechnology, Huntsville, Alabama 35806, USA.ORCID 0009-0009-4381-7540
Jacob M LoupeHudsonAlpha Institute for Biotechnology, Huntsville, Alabama 35806, USA.ORCID 0000-0003-1927-9649
Ivan Rodriguez-NunezHudsonAlpha Institute for Biotechnology, Huntsville, Alabama 35806, USA.ORCID 0000-0002-9947-8981
Stephanie A FelkerHudsonAlpha Institute for Biotechnology, Huntsville, Alabama 35806, USA.ORCID 0000-0002-1809-1524
James M J LawlorHudsonAlpha Institute for Biotechnology, Huntsville, Alabama 35806, USA.ORCID 0000-0003-1735-1766
William E BunneyDepartment of Psychiatry and Human Behavior, University of California, Irvine, California 92697, USA.ORCID 0000-0002-4166-0836
Blynn G BunneyDepartment of Psychiatry and Human Behavior, University of California, Irvine, California 92697, USA.ORCID 0000-0001-5483-3284
Preston M CartagenaDepartment of Psychiatry and Human Behavior, University of California, Irvine, California 92697, USA.
Adolfo SequeiraDepartment of Psychiatry and Human Behavior, University of California, Irvine, California 92697, USA.ORCID 0000-0003-3040-1190
Stanley J WatsonThe Michigan Neuroscience Institute, University of Michigan, Ann Arbor, Michigan 48109, USA.ORCID 0000-0003-4980-5523
Huda AkilThe Michigan Neuroscience Institute, University of Michigan, Ann Arbor, Michigan 48109, USA.ORCID 0000-0003-0623-1056
Eric M MendenhallHudsonAlpha Institute for Biotechnology, Huntsville, Alabama 35806, USA.ORCID 0000-0002-7395-6295
Gregory M CooperHudsonAlpha Institute for Biotechnology, Huntsville, Alabama 35806, USA; rmyers@hudsonalpha.org gcooper@hudsonalpha.org.ORCID 0000-0001-5509-9923
Richard M MyersHudsonAlpha Institute for Biotechnology, Huntsville, Alabama 35806, USA; rmyers@hudsonalpha.org gcooper@hudsonalpha.org.ORCID 0000-0001-9701-676X

Funding

Transcription factor function in healthy and psychiatric disorder-affected brainsR01MH110472 · NIMH · HUDSON-ALPHA INSTITUTE FOR BIOTECHNOLOGY · PI COOPER, GREGORY MICHAEL, MYERS, RICHARD M · 2017 to 2021
$6.0M
NIMH NIH HHS R01 MH110472
6 · The paper itself

Abstract

Transcription factors (TFs) regulate gene expression by facilitating or disrupting the formation of transcription initiation machinery at particular genomic loci. Because TF occupancy is driven in part by recognition of DNA sequence, genetic variation can influence TF-DNA associations and gene regulation. To identify variants that impact TF binding in human brain tissues, we assessed allele-specific binding (ASB) at heterozygous variants for 94 TFs in nine brain regions from two donors. Leveraging graph genomes constructed from phased genomic sequence data, we compared ChIP-seq signals between alleles at heterozygous variants within each brain region and identified thousands of variants exhibiting ASB for at least one TF. ASB reproducibility was measured by comparisons between independent experiments both within and between donors. We found that rare alleles in the general population more frequently led to reduced TF binding, whereas common alleles had an equal likelihood of increasing or decreasing binding. Further, for ASB variants in predicted binding motifs, the favored allele tended to be the one with the stronger expected motif match, but this concordance was not observed within highly occupied sites. We also found that neuron-specific

Indexed as

AllelesBrainQuantitative Trait LociTranscription FactorsBinding SitesChromatin Immunoprecipitation SequencingGene Expression RegulationHumansNeuronsPolymorphism, Single NucleotideProtein BindingTranscription Factors

Identifiers

PMID39152038
PMCPMC11444172

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.